Dibenzyl ((1R,3S)-cyclohexane-1,3-diyl)dicarbamate

Catalog No.: 
ACKVSH522
CAS No.: 
2177267-76-2
Molecular Formula: 
C22H26N2O4
Molecular Weight: 
382.46
Dibenzyl ((1R,3S)-cyclohexane-1,3-diyl)dicarbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%
1g95%
5g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDibenzyl ((1R,3S)-cyclohexane-1,3-diyl)dicarbamate
IUPAC Namedibenzyl ((1R,3S)-cyclohexane-1,3-diyl)dicarbamate
Molecular FormulaC22H26N2O4
Molecular Weight382.46
SMILESO=C(OCC1=CC=CC=C1)N[C@H]2C[C@@H](NC(OCC3=CC=CC=C3)=O)CCC2
InChI KeyUEBNNFJJFCKAFD-BGYRXZFFSA-N
SynonymBenzyl N-[(1R,3S)-3-(phenylmethoxycarbonylamino)cyclohexyl]carbamate;Dibenzyl (1R,3S)-cyclohexane-1,3-diyldicarbamate
CAS No.2177267-76-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACKVSH522 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKZLC502 route compound structure diagram
    ACKZLC5021932063-48-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKVSH522 route product structure diagram
    ACKVSH5222177267-76-2
Inquiry

2. ACKVSH522 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKVSH522 route product structure diagram
    ACKVSH5222177267-76-2
Inquiry

3. ACKVSH522 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKVSH522 route product structure diagram
    ACKVSH5222177267-76-2
Inquiry

Comments (0)